Odze R - Search Results

1

Deletion at fragile sites is a common and early event in Barrett's esophagus.

Lai LA, Kostadinov R, Barrett MT, Peiffer DA, Pokholok D, Odze R, Sanchez CA, Maley CC, Reid BJ, Gunderson KL, Rabinovitch PS. Lai LA, et al. Among authors: odze r. Mol Cancer Res. 2010 Aug;8(8):1084-94. doi: 10.1158/1541-7786.MCR-09-0529. Epub 2010 Jul 20. Mol Cancer Res. 2010. PMID: 20647332 Free PMC article.

2

Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.

Zhuang Z, Vortmeyer AO, Mark EJ, Odze R, Emmert-Buck MR, Merino MJ, Moon H, Liotta LA, Duray PH. Zhuang Z, et al. Among authors: odze r. Cancer Res. 1996 May 1;56(9):1961-4. Cancer Res. 1996. PMID: 8616831

3

Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.

Torres C, Turner JR, Wang HH, Richards W, Sugarbaker D, Shahsafaei A, Odze RD. Torres C, et al. Among authors: odze rd. Cancer. 1999 Feb 1;85(3):520-8. Cancer. 1999. PMID: 10091725

4

Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.

Hornick JL, Blount PL, Sanchez CA, Cowan DS, Ayub K, Maley CC, Reid BJ, Odze RD. Hornick JL, et al. Am J Surg Pathol. 2005 Mar;29(3):372-80. doi: 10.1097/01.pas.0000147403.33509.de. Am J Surg Pathol. 2005. PMID: 15725807

5

Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.

Kristal AR, Blount PL, Schenk JM, Sanchez CA, Rabinovitch PS, Odze RD, Standley J, Vaughan TL, Reid BJ. Kristal AR, et al. Among authors: odze rd. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2377-83. doi: 10.1158/1055-9965.EPI-05-0158. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16214920 Clinical Trial.

6

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.

Vaughan TL, Dong LM, Blount PL, Ayub K, Odze RD, Sanchez CA, Rabinovitch PS, Reid BJ. Vaughan TL, et al. Lancet Oncol. 2005 Dec;6(12):945-52. doi: 10.1016/S1470-2045(05)70431-9. Lancet Oncol. 2005. PMID: 16321762

7

Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.

Wongsurawat VJ, Finley JC, Galipeau PC, Sanchez CA, Maley CC, Li X, Blount PL, Odze RD, Rabinovitch PS, Reid BJ. Wongsurawat VJ, et al. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):509-16. doi: 10.1158/1055-9965.EPI-05-0246. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16537709

8

Neosquamous epithelium does not typically arise from Barrett's epithelium.

Paulson TG, Xu L, Sanchez C, Blount PL, Ayub K, Odze RD, Reid BJ. Paulson TG, et al. Clin Cancer Res. 2006 Mar 15;12(6):1701-6. doi: 10.1158/1078-0432.CCR-05-1810. Clin Cancer Res. 2006. PMID: 16551852

9

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

Lomo LC, Blount PL, Sanchez CA, Li X, Galipeau PC, Cowan DS, Ayub K, Rabinovitch PS, Reid BJ, Odze RD. Lomo LC, et al. Am J Surg Pathol. 2006 Apr;30(4):423-35. doi: 10.1097/00000478-200604000-00001. Am J Surg Pathol. 2006. PMID: 16625087

10

Chromosomal instability in Barrett's esophagus is related to telomere shortening.

Finley JC, Reid BJ, Odze RD, Sanchez CA, Galipeau P, Li X, Self SG, Gollahon KA, Blount PL, Rabinovitch PS. Finley JC, et al. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1451-7. doi: 10.1158/1055-9965.EPI-05-0837. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters